HK1148669A1 - C-19 steroids for cosmetic and further uses - Google Patents

C-19 steroids for cosmetic and further uses

Info

Publication number
HK1148669A1
HK1148669A1 HK11102719.3A HK11102719A HK1148669A1 HK 1148669 A1 HK1148669 A1 HK 1148669A1 HK 11102719 A HK11102719 A HK 11102719A HK 1148669 A1 HK1148669 A1 HK 1148669A1
Authority
HK
Hong Kong
Prior art keywords
skin
steroids
present
influencing
cosmetic
Prior art date
Application number
HK11102719.3A
Other languages
English (en)
Inventor
Martin Windisch
Original Assignee
Erlacos Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erlacos Gmbh filed Critical Erlacos Gmbh
Publication of HK1148669A1 publication Critical patent/HK1148669A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
HK11102719.3A 2007-11-13 2011-03-18 C-19 steroids for cosmetic and further uses HK1148669A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US288207P 2007-11-13 2007-11-13
EP07022015.7A EP2060261B1 (en) 2007-11-13 2007-11-13 C-19 steroids for cosmetic uses
PCT/EP2008/009540 WO2009062682A1 (en) 2007-11-13 2008-11-12 C-19 steroids for cosmetic and further uses

Publications (1)

Publication Number Publication Date
HK1148669A1 true HK1148669A1 (en) 2011-09-16

Family

ID=39198683

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11102719.3A HK1148669A1 (en) 2007-11-13 2011-03-18 C-19 steroids for cosmetic and further uses

Country Status (11)

Country Link
US (1) US8258123B2 (xx)
EP (2) EP2060261B1 (xx)
JP (1) JP2011503129A (xx)
KR (2) KR20100087005A (xx)
CN (1) CN101854908B (xx)
AU (1) AU2008323198B2 (xx)
CA (1) CA2705529C (xx)
DK (1) DK2060261T3 (xx)
ES (1) ES2574933T3 (xx)
HK (1) HK1148669A1 (xx)
WO (1) WO2009062682A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2500062T3 (en) * 2007-11-13 2015-09-21 Curadis Gmbh C-19 steroids to specific therapeutic applications,
US11850451B2 (en) 2011-01-31 2023-12-26 Lucolas-M.D. Ltd. Cosmetic compositions and methods for improving skin conditions
JP5872806B2 (ja) * 2011-07-07 2016-03-01 花王株式会社 Ｍｆａｐ−４産生促進剤
EP2574329A1 (en) * 2011-09-28 2013-04-03 ErlaCos GmbH Deodorant comprising dimethyl isosorbide
JP5980512B2 (ja) * 2012-01-30 2016-08-31 学校法人東日本学園 体臭抑制剤
JP6145181B2 (ja) * 2016-01-14 2017-06-07 花王株式会社 Ｍｆａｐ−４産生促進剤
BR112019001349A2 (pt) * 2016-08-03 2019-04-30 Colgate Palmolive Co agente ativo e método para reduzir o mau odor
FR3094229B1 (fr) * 2019-03-28 2021-11-12 Roquette Freres Composition topique pour le traitement des mauvaises odeurs corporelles, notamment l’halitose

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2763818A (en) * 1954-10-14 1956-09-18 Westinghouse Electric Corp Lighting arrester
US2762818A (en) 1955-05-26 1956-09-11 Searle & Co 4-hydroxytestosterone and esters thereof
ZA843232B (en) * 1983-05-03 1984-12-24 Bristol Myers Co Antiperspirant stick with low staining potential
JPS62132810A (ja) 1985-12-05 1987-06-16 Shiseido Co Ltd 化粧料
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
EP0555309A1 (en) 1990-10-31 1993-08-18 BEECHAM GROUP plc Topical composition with retinoid penetration enhancer
US5486511A (en) 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
JPH10508828A (ja) * 1994-09-14 1998-09-02 セントラル シェフィールド ユニバーシティ ホスピタルズ エヌエイチエス トラスト 毛髪成長の制御
US5824326A (en) * 1997-06-27 1998-10-20 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Activity enhancement of ferulic acid with dimethyl isosorbride in cosmetic compositions
AU2002330031B2 (en) 2001-09-21 2007-07-05 Merck & Co., Inc. Androstanes as androgen receptor modulators
US20030199487A1 (en) 2002-04-22 2003-10-23 Mr. Vince Paternoster Ester and ether derivatives of 4-hydroxytestosterone and a method for the regulation of athletic function in humans
US6586417B1 (en) * 2002-04-22 2003-07-01 Nutrisport Pharmacal, Inc. Ester and ether derivatives of 4-hydroxy 4-androstene-3,17-dione and a method for the regulation of athletic function in humans
US20030229063A1 (en) 2002-06-05 2003-12-11 Llewellyn William Charles Use of 4-hydroxytestosterone to lower estrogen levels in humans
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
JP2007509151A (ja) * 2003-10-21 2007-04-12 ダイアド ファーマシューティカル コーポレーション ５α−レダクターゼ１型及び２型依存性症状を治療するための方法及び組成物
AU2004308260A1 (en) 2003-12-12 2005-07-14 University Of Rochester Non-androgen dependent roles for androgen receptor and non-androgen related inhibitors of androgen receptor
WO2006084312A1 (en) 2005-02-09 2006-08-17 Acrux Dds Pty Ltd Method of promoting hair growth
JP4755845B2 (ja) * 2005-04-28 2011-08-24 共栄化学工業株式会社 テストステロン−５α−リダクターゼ阻害剤及びテストステロン−５α−リダクターゼ阻害剤を含有する化粧料。
EP1854465A1 (en) * 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers

Also Published As

Publication number Publication date
WO2009062682A1 (en) 2009-05-22
EP2060261B1 (en) 2016-03-09
CN101854908A (zh) 2010-10-06
CA2705529C (en) 2016-10-11
EP2060261A1 (en) 2009-05-20
US8258123B2 (en) 2012-09-04
CA2705529A1 (en) 2009-05-22
US20100256102A1 (en) 2010-10-07
ES2574933T3 (es) 2016-06-23
KR20160036098A (ko) 2016-04-01
JP2011503129A (ja) 2011-01-27
AU2008323198A1 (en) 2009-05-22
KR20100087005A (ko) 2010-08-02
AU2008323198B2 (en) 2014-03-20
DK2060261T3 (en) 2016-06-13
EP2207523A1 (en) 2010-07-21
KR101776544B1 (ko) 2017-09-07
CN101854908B (zh) 2013-03-06

Similar Documents

Publication Publication Date Title
HK1148669A1 (en) C-19 steroids for cosmetic and further uses
MX2010006172A (es) Composicion antitranspirante y/o desodorante solida en forma de una emulsion de agua en aceite basada en emulsionadores de silicona particulares y en ceras particulares; metodo de tratamiento de olores corporales.
WO2003039505A3 (de) Beta-glucuronidase-inhibitoren in deodorantien und antitranspirantien
WO2008006076A3 (en) Alkyl lactyllactates and processes of making the same
MY148437A (en) Pigmentation-regulating compounds
SG161269A1 (en) Personal care compositions comprising silicone resins with enhanced properties, method of manufacture, and method of use thereof
WO2001099376A3 (de) Arylsulfatase-inhibitoren in deodorantien und antitranspirantien
TW200600092A (en) Topical slimming preparation and a cosmetic containing a carnitine derivative
EA200801773A1 (ru) Глюкопиранозилзамещенные производные бензонитрила, фармацевтические композиции, содержащие такие соединения, их применение и способ их получения
BRPI0409372A (pt) composições e métodos para regular o tecido queratinoso de mamìferos
MX341211B (es) Sintesis de un nuevo antioxidante de nitroxido y metodos de uso en composiciones cosmeticas y dermatologicas.
EP1739132A3 (en) Cosmetic or pharmaceutical compositions comprising modified polyorganosiloxanes
HK1147695A1 (en) Pharmaceutical solid state forms
WO2010025894A3 (en) Conditioning composition for hair
ATE543486T1 (de) Kosmetische und dermatologische zusammensetzungen,insbesondere für die behandlung keratinhaltiger substrate
WO2004108063A3 (fr) Utilisation cosmetique des sophorolipides comme agents amincissants
EP4299077A3 (en) Skin enhancing compositions and methods
WO2012143845A3 (en) New cosmetic and therapeutical uses of ghk tripeptide
BRPI0410369A (pt) composições compreendendo uma amidina e um alcano poliol
CA2001938A1 (en) Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
JP2011503129A5 (xx)
MX2015009015A (es) Composicion cosmetica o dermatologica que comprende una merocianina, un agente de filtro ultravioleta b (uvb) organico y un agente de filtro ultravioleta a (uva) organico adicional.
WO2014111563A3 (en) Cosmetic or dermatological composition comprising a merocyanine and a lipophilic benzotriazole uv-screening agent and/or a bis-resorcinyl triazine compound
FR2973226B1 (fr) Utilisation de composes (ethoxy-hydroxyphenyl)alkylcetone ou ethoxyhydroxyalkylphenol pour traiter la peau grasse
KR950025035A (ko) 코지산 유도체

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211112